Veterinary Injectable Devices Market Analysis

  • Report ID: 871
  • Published Date: Jul 22, 2024
  • Report Format: PDF, PPT

Veterinary Injectable Devices Market Analysis

Usability (Disposable, Re-Usable)

The disposable segment in the veterinary injectable devices market is poised to hold the largest revenue share. Moreover, the disposable devices category held a revenue of USD 30 Million in 2022 and is anticipated to grow by 5% by 2036. The emphasis on a high level of security, reduced risk of infections, convenience, and time effectiveness for veterinarians, together with cost-effectiveness are factors that contribute to the increased demand for disposable devices in the animal health sector.

End-User (Veterinary Hospitals, Veterinary Clinics)

The veterinary clinics segment is expected to hold 55% share of the global veterinary injectable devices market during the forecast period.  Also, the market showcased a significant share of the market at 44% in the year, 2022. The demand for veterinary services is increasing owing to the growing popularity of pet ownership, shifting demographics, and the growing awareness of animal healthcare. A major provider of animal health services is the veterinary clinic.

Our in-depth analysis of the global veterinary injectable devices market includes the following segments:

        Product

  • Syringes
  • Needles
  • Remote Drug Delivery System
  • Needle Free Injection System

        Usability

  • Disposable
  • Re-Usable

        Materials

  • Glass
  • Metal
  • Plastic

       End-User

  • Veterinary Hospitals
  • Veterinary Clinics
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 871
  • Published Date: Jul 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of veterinary injectable devices is assessed at USD 942.65 Million.

The veterinary injectable devices market size was valued at USD 900.51 Million in 2023 and is likely to reach USD 1.74 Billion by the end of 2036, expanding at around 5.2% CAGR during the forecast period i.e., between 2024-2036. Growing demand for animal healthcare, advancements in technology and increasing prevalence of zoonotic diseases is driving the market growth.

North America industry is expected to garner the largest revenue share of 35% by 2036, propelled by presence of better healthcare facilities in the region.

Boehringer Ingelheim International GmbH, NuGen Medical Devices Inc, NEOGEN Corporation, Phibro Animal Health, Zoetis Inc
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample